No recent public news coverage is available for Research Alliance Corp III as of the report date.

The company’s successful IPO and substantial trust account balance provide financial resources to pursue a business combination. The sponsor’s commitment to provide working capital loans may support transaction-related expenses. The company’s management has discretion to identify and negotiate with potential targets, which could lead to value creation through a successful business combination.

The company has not selected any business combination target and has not engaged in substantive discussions, creating uncertainty about the timing and success of a business combination. The company has a working capital deficit and reported a net loss related to formation expenses. There is no assurance that the company will complete a business combination successfully, and failure to do so could result in liquidation and loss of invested capital. The company’s internal controls have material weaknesses, which may affect financial reporting reliability.

As a blank check company without operations or a completed business combination, Research Alliance Corp III currently has no competitive moat. Its value proposition depends on the ability to identify and consummate a business combination with a suitable target, which is subject to market and execution risks. The company’s moat will be determined by the competitive position and business model of the post-combination entity, which is not yet identified.

• Business Combination Uncertainty: The company has not identified or engaged with any business combination target, and there is no assurance that it will complete a business combination successfully.
• Liquidity and Working Capital Deficit: As of March 31, 2026, the company had a working capital deficit and relies on sponsor loans and IPO proceeds to fund operations and transaction costs.
• Emerging Growth Company Risks: The company is subject to risks associated with emerging growth companies, including limited operating history and reduced disclosure requirements.
• Internal Control Weaknesses: The company reported material weaknesses in internal controls over financial reporting, which may impact the accuracy and completeness of financial statements.
• Redemption Rights: Public shares contain redemption features that may affect the company’s capital structure and liquidity in connection with the business combination or liquidation.

• Research Alliance Corp III is a blank check company incorporated in the Cayman Islands on February 19, 2026, formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
• As of March 31, 2026, the company had not commenced any operations and had no revenues; all activity related to formation and the initial public offering (IPO).
• The company completed its IPO on May 21, 2026, issuing 7,500,000 Class A ordinary shares at $10.00 per share, generating gross proceeds of $75 million, with approximately $3.7 million in offering costs.
• Simultaneously with the IPO, the company completed a private placement of 275,000 Class A ordinary shares, generating gross proceeds of $2.75 million.
• Following the IPO, $75 million of net proceeds were deposited in a trust account held in cash or invested in U.S. government securities or money market funds until the earlier of the completion of a business combination or distribution of the trust account.
• The company has broad discretion over the use of net proceeds but intends to apply substantially all funds toward consummating a business combination.
• As of March 31, 2026, the company had cash of $280,275, other current assets of $2,600, deferred offering costs of $450,042, total assets of $732,917, and total current liabilities of $773,166, resulting in a working capital deficit of $490,291.
• The company reported a net loss of $65,249 for the period from inception through March 31, 2026, consisting entirely of formation, general, and administrative expenses.
• The weighted average ordinary shares outstanding for the period was 1,129,842, with basic and diluted net loss per share of $0.06.
• The company’s sponsor is Research Alliance Holdings III, LLC, which provided a $300,000 promissory note to fund initial expenses, repaid upon IPO closing.
• The company may receive working capital loans from the sponsor or affiliates to finance transaction costs related to the business combination, which may be convertible into shares post-combination.
• The company has not selected any specific business combination target and has not engaged in substantive discussions with any target as of the latest filing.
• The company is an emerging growth company and is subject to related risks and reduced disclosure obligations under the JOBS Act.
• The company’s Class A ordinary shares are listed on the Nasdaq Capital Market under the ticker RACC.
• The company’s management reviews financial performance as a single operating segment, as no operations have commenced.
• The company’s public shares contain a redemption feature related to liquidation or shareholder vote in connection with the initial business combination.
• The company’s deferred offering costs include underwriting commissions, discounts, and other offering expenses, some of which are deferred and payable only upon completion of a business combination.
• The company’s financial statements are prepared in accordance with U.S. GAAP and include standard disclosures on income taxes, share-based compensation, and risk factors.
• The company’s liquidity needs prior to IPO were satisfied through sponsor loans and payments, with no working capital loans outstanding as of March 31, 2026.
• The company’s internal controls over financial reporting were not effective as of March 31, 2026, due to difficulties in accounting for accounts payable and accrued expenses, reported as a material weakness.
• The company is not currently a party to any material litigation or legal proceedings as of the latest filing.